Savant Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.6M | Buy |
163,461
+849
| +0.5% | +$188K | 0.17% | 80 |
|
|
2025
Q4 | $37.2M | Buy |
162,612
+22,204
| +16% | +$5.06M | 0.21% | 76 |
|
|
2025
Q3 | $32.5M | Buy |
140,408
+1,228
| +0.9% | +$250K | 0.2% | 76 |
|
|
2025
Q2 | $25.8M | Buy |
139,180
+15,754
| +13% | +$2.93M | 0.19% | 83 |
|
|
2025
Q1 | $25.9M | Sell |
123,426
-31,056
| -20% | -$6.04M | 0.22% | 74 |
|
|
2024
Q4 | $27.5M | Buy |
154,482
+653
| +0.4% | +$120K | 0.22% | 79 |
|
|
2024
Q3 | $30.4M | Buy |
153,829
+12,796
| +9% | +$2.39M | 0.25% | 70 |
|
|
2024
Q2 | $24.2M | Buy |
141,033
+3,220
| +2% | +$533K | 0.24% | 75 |
|
|
2024
Q1 | $25.1M | Sell |
137,813
-45
| -0% | -$7.75K | 0.29% | 61 |
|
|
2023
Q4 | $21.4M | Buy |
137,858
+529
| +0.4% | +$77.1K | 0.28% | 64 |
|
|
2023
Q3 | $20.5M | Buy |
137,329
+9,130
| +7% | +$1.34M | 0.31% | 60 |
|
|
2023
Q2 | $17.3M | Buy |
128,199
+34,985
| +38% | +$5.13M | 0.27% | 69 |
|
|
2023
Q1 | $14.9M | Buy |
93,214
+2,555
| +3% | +$391K | 0.28% | 64 |
|
|
2022
Q4 | $14.6M | Buy |
90,659
+10,434
| +13% | +$1.6M | 0.36% | 46 |
|
|
2022
Q3 | $10.8M | Sell |
80,225
-5,688
| -7% | -$816K | 0.34% | 48 |
|
|
2022
Q2 | $13.2M | Buy |
85,913
+5,483
| +7% | +$838K | 0.4% | 44 |
|
|
2022
Q1 | $13M | Sell |
80,430
-565
| -0.7% | -$82.1K | 0.43% | 42 |
|
|
2021
Q4 | $11M | Sell |
80,995
-554
| -0.7% | -$65.4K | 0.35% | 46 |
|
|
2021
Q3 | $8.8M | Buy |
81,549
+2,185
| +3% | +$250K | 0.32% | 49 |
|
|
2021
Q2 | $8.94M | Sell |
79,364
-3
| -0% | -$338 | 0.36% | 42 |
|
|
2021
Q1 | $8.59M | Buy |
79,367
+4,179
| +6% | +$447K | 0.46% | 38 |
|
|
2020
Q4 | $8.06M | Buy |
75,188
+1,262
| +2% | +$121K | 0.47% | 39 |
|
|
2020
Q3 | $6.47M | Buy |
73,926
+88
| +0.1% | +$8.29K | 0.44% | 46 |
|
|
2020
Q2 | $7.25M | Sell |
73,838
-945
| -1% | -$83.2K | 0.55% | 36 |
|
|
2020
Q1 | $5.7M | Buy |
74,783
+15,008
| +25% | +$1.28M | 0.54% | 42 |
|
|
2019
Q4 | $5.29M | Sell |
59,775
-221
| -0.4% | -$18.3K | 0.65% | 36 |
|
|
2019
Q3 | $4.54M | Sell |
59,996
-1,515
| -2% | -$104K | 0.63% | 39 |
|
|
2019
Q2 | $4.47M | Sell |
61,511
-1,936
| -3% | -$152K | 0.63% | 37 |
|
|
2019
Q1 | $5.11M | Sell |
63,447
-186
| -0.3% | -$15.2K | 0.96% | 22 |
|
|
2018
Q4 | $5.87M | Sell |
63,633
-360
| -0.6% | -$31.7K | 1.23% | 18 |
|
|
2018
Q3 | $6.05M | Buy |
63,993
+114
| +0.2% | +$10.8K | 1.09% | 19 |
|
|
2018
Q2 | $5.92M | Buy |
63,879
+1,938
| +3% | +$189K | 1.26% | 13 |
|
|
2018
Q1 | $5.86M | Buy |
61,941
+1,985
| +3% | +$218K | 1.24% | 13 |
|
|
2017
Q4 | $5.8M | Sell |
59,956
-737
| -1% | -$69.5K | 1.22% | 14 |
|
|
2017
Q3 | $5.39M | Sell |
60,693
-439
| -0.7% | -$33.4K | 1.21% | 15 |
|
|
2017
Q2 | $4.43M | Buy |
61,132
+793
| +1% | +$53.3K | 1.05% | 15 |
|
|
2017
Q1 | $3.93M | Sell |
60,339
-2,680
| -4% | -$168K | 0.97% | 17 |
|
|
2016
Q4 | $3.95M | Sell |
63,019
-781
| -1% | -$47.7K | 1.06% | 16 |
|
|
2016
Q3 | $4.02M | Sell |
63,800
-5
| -0% | -$324 | 1.11% | 14 |
|
|
2016
Q2 | $3.95M | Buy |
63,805
+2,857
| +5% | +$174K | 1.13% | 13 |
|
|
2016
Q1 | $3.48M | Sell |
60,948
-1,447
| -2% | -$80.7K | 1.06% | 13 |
|
|
2015
Q4 | $3.7M | Buy |
62,395
+2,148
| +4% | +$124K | 1.15% | 12 |
|
|
2015
Q3 | $3.28M | Buy |
60,247
+21,831
| +57% | +$1.42M | 1.17% | 14 |
|
|
2015
Q2 | $2.58M | Buy |
38,416
+465
| +1% | +$30.4K | 0.87% | 18 |
|
|
2015
Q1 | $2.22M | Buy |
37,951
+126
| +0.3% | +$7.61K | 0.79% | 17 |
|
|
2014
Q4 | $2.48M | Buy |
37,825
+1,701
| +5% | +$107K | 0.94% | 16 |
|
|
2014
Q3 | $2.09M | Buy |
36,124
+2,803
| +8% | +$156K | 0.89% | 18 |
|
|
2014
Q2 | $1.88M | Buy |
33,321
+20
| +0.1% | +$1.05K | 0.81% | 19 |
|
|
2014
Q1 | $1.71M | Sell |
33,301
-978
| -3% | -$49.4K | 0.79% | 21 |
|
|
2013
Q4 | $1.81M | Buy |
34,279
+272
| +0.8% | +$13.4K | 0.89% | 21 |
|
|
2013
Q3 | $1.52M | Sell |
34,007
-128
| -0.4% | -$5.67K | 0.83% | 23 |
|
|
2013
Q2 | $1.41M | Buy |
+34,135
| New | +$1.49M | 0.82% | 24 |
|
Other funds holding ABBV
VCM
VPM
Savant Capital's ABBV Position: Q1 2026 in Review
Savant Capital increased its AbbVie (ABBV) stake by 0.52% in Q1 2026, buying an estimated $188K and bringing the position to 163,461 shares worth $35.6M. The position accounts for 0.17% of the portfolio, ranked #80.
Savant Capital first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.2M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Savant Capital held 163,461 shares of AbbVie worth $35.6M as of Q1 2026.
- Savant Capital bought 849 AbbVie shares in Q1 2026, an estimated $188K.
- AbbVie made up 0.17% of Savant Capital's portfolio in Q1 2026, its #80 holding.
- Savant Capital first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Savant Capital's AbbVie position peaked at $37.2M in Q4 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.